In a letter this week to the Accredited Standards Committee X12, Medicare’s acting administrator, Andrew M. Slavitt, along with FDA Commissioner Robert M. Califf, encouraged the use of the ID number in medical bills and claims, called a unique device identifier, saying the change “would allow for evaluation of product performance and identification of safety concerns for devices at the model level.”
They said the change also would help providers and certain payers calculate and compare total costs and outcomes based on the device model used, among other benefits.
The proposal has long been advocated by many lawmakers and officials at the FDA, the report notes.
Proponents of the use of UDIs contend the move is crucial in helping detect malfunctions in devices such as heart defibrillators, blood filters and hip and knee joints, according to The Wall Street Journal.
AdvaMed, a medical device industry group, told the publication it supported the development of UDIs but that using them in billing systems is a “challenging and complex proposition” that needs to be evaluated further to ensure it is practical.
Ultimately, whether the change occurs depends on a decision from the ASC X12, a committee of the medical billing industry. According to the report, that panel is scheduled to make specific recommendations to the industry by December.
More articles on supply chain:
4 reasons adults need vaccines just as much as kids
Drug shortages force workarounds in Conn. hospitals
Philips partners with Life-Assist to boost AED supplies in west coast
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.